Build an AI Acute Stroke Detection and Triage Platform

1. 1

   Choose a cleared indication and clinical claim

   Do not try to detect everything. Start with a specific, defensible claim such as large vessel occlusion detection on CT angiography or intracranial hemorrhage flagging on non-contrast CT, and design the model and its FDA submission around it. The claim you make determines your evidence burden, your clearance pathway, and your liability. A tight, clinically validated first indication is how these platforms reach market and expand from there.

2. 2

   Assemble training data and clinical validation

   A stroke-triage model needs large, well-labeled imaging datasets and rigorous validation against clinician ground truth, ideally across diverse scanners and populations so performance generalizes. Real-world impact evidence, like the study across more than 450,000 patients associated with a 100 percent increase in thrombectomy rates, is what wins hospital trust. Invest in clinical validation as heavily as in the model, because hospitals buy proof, not accuracy claims alone.

3. 3

   Clear the FDA and build the SaMD quality system

   As Software as a Medical Device, the platform must clear the FDA before it can be sold for clinical use, and you must operate a compliant quality and post-market surveillance system. Engage regulatory leadership or a neuro-AI SaMD consultant (a separate card in this file) early, because the clearance strategy shapes the whole timeline and budget. Expect 3 to 6 years and several million dollars from start to a cleared, sellable product.

4. 4

   Build for hospital integration from day one

   The platform has to slot into hospital imaging and stroke workflows: PACS and imaging systems, real-time alerting to stroke teams on their phones, and IT and security review. Integration is the slowest, most expensive part of the sale, so design for interoperability and compliance early. A brilliant model that does not fit the stroke workflow will not get adopted, because the value is speed inside a live clinical pathway, not standalone accuracy.

5. 5

   Survive the enterprise hospital sales cycle

   Comprehensive stroke centers and hospital systems are the buyers, and enterprise health-system sales run long, involve committees, and demand clinical evidence, ROI, and security assurances. You are also competing against established platforms and major imaging vendors named among the market leaders. Fund a runway that assumes long sales cycles, land reference hospitals with strong outcomes, and expand from there. This card is deliberately distinct from general radiology-AI cards in the bank: it is stroke-specific, acute, and time-critical.

Do not take our word for the money. Put your own numbers in and see what this idea has to earn before it works. Free, instant, no account needed.

Best for: Funded medical-AI teams with imaging, clinical, and regulatory depth, not solo or first-time founders

Not for: This is not for a solo founder, a bootstrapper, or anyone expecting a fast launch. It is one of the highest-capital, longest-runway ventures in this file, suited only to funded teams with imaging-AI, clinical, and regulatory depth. Those wanting a lower-capital stroke play should look at the portable point-of-care stroke hardware card, which is also hard but different.